When might the planned 24/7 health service eventuate?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
an hour ago
- Otago Daily Times
Staff praised amid spike in ED visits
Christchurch Hospital's emergency department may have had its largest number of patients ever in one day. A source at the hospital told The Star 470 patients were at ED on Sunday, July 13. But Health New Zealand told The Star on Monday it could not confirm the number of patients or whether it was the most ever. To confirm patient numbers, the agency would need an Official Information Act request, which can take up to 20 days to process, a spokesperson said. Health NZ Canterbury director of operations, Hamish Brown, said recent weeks have been busier than usual for this time of year. 'This month our team is seeing an average 414 patients a day, which is nearly an 8% increase from the same time last year,' he said. Brown said the ED staff have been 'fantastic' at handling the patient increase but due to high demand, those with non-emergency needs may face long waits. 'We would like to thank those who are waiting for their patience and understanding, as well as our teams across the hospital.' Brown attributed the spike in patients to an increase in winter viral and respiratory illnesses, along with Sundays typically being one of the busiest days of the week. Weekends often involve more high-risk activities, and many GPs and other health clinics are often closed on Sundays, pushing more patients toward ED. To manage the high demand, Brown said the ED has introduced various initiatives, and are working on other options. They include the opening of an ED observation area to reduce hospital admissions, fast-track admission pathways, and offering alternative options for care to patients with less urgent needs. It comes as RNZ reported relatives of distressed patients at Christchurch Hospital have been asked to come in to help because of a shortage of healthcare assistants. Information provided by a hospital staff member showed the hospital had so few healthcare assistants on June 22, managers were asked to see if patients' family members could come in to sit with and monitor them. This is usually done for patients with confusion, delirium, or dementia symptoms. Health NZ's Canterbury director of nursing Becky Hickmott said the issue was caused by a large volume of patients, coupled with a significant number of staff who rang in sick at short notice.
RNZ News
7 hours ago
- RNZ News
What's going on with Rocket Lab shares?
Photo: RNZ/ Nate McKinnon Rocket Lab may be recording multi-million-dollar losses, but its share price keeps on going up. Shares in the New Zealand-founded space company have risen more than 800 percent in the past year, to just under US$50 each. In August last year, they were changing hands for less than US$5. In its 2024 financial year, the company recorded a loss of US$33 million to US$35m, from record annual revenue of US$436.2m. Greg Smith, head of retail at Devon Funds, said investors were looking past the lack of profitability, and there was a lot of momentum priced in to its shares. "But the company has been delivering. It is gaining huge credibility through deals with national space agencies and spending here has been ramping up. There's been the recent partnership agreed with the European Space Agency to launch satellites for constellation navigation before December. "And there has been a string of successful launches. A rocket is being produced every 15 days, and [it has] successfully launched its 66th, 67th and 68th Electron rockets." He said the company's upcoming, bigger Neutron medium-lift rocket was another driver of growth. If it was successful, it could unlock US$5.6 billion in National Security Space Launch contracts. "The company isn't profitable yet, so we can't really look at earnings multiples. Even to sales it is looking high at up to 10 times, but if it keeps delivering we might yet see more momentum." Gretjan Verdickt, a lecturer of finance at the University of Auckland, said a significant portion of Rocket Lab's current valuation was based on the promise of a future that was "both exciting and challenging to value". "How much will the space economy truly be worth in 10 or 20 years? How many applications will it lead to? It's difficult for anyone to grapple with. Because of that uncertainty, optimistic investors are willing to pay a very high price today for the potential of a massive payoff down the road. They see a leader in a burgeoning industry and don't want to miss out. "This part of the valuation is precarious. A narrative of explosive growth and future dominance sustains it. If that optimism fades, even slightly, you could see a significant drop. That said, for anyone who got in early, a drop would still leave them with an amazing return." He said the "hype-driven" component of the share price made it fragile. "If you think about it from a behavioural finance point of view, there is a lot of 'fear of missing out' going on too. If you missed the boat at 100 percent, 200 percent... and you jump in late, the prices - because you are willing to buy - the stock price increases more. This leads to a momentum effect." He said the other aspect of the share price was the company's cash flow. "There is a real, tangible business generating real cash flows behind the stock price. "Rocket Lab has already realised tremendous growth. Their revenue has increased significantly over the past few years, and they have a backlog of over $1 billion in signed contracts, providing a clear line of sight into future earnings. "They have two core pillars of growth. First, their proven Electron rocket is a workhorse for the small satellite market. Second, and more importantly for the future, is their upcoming Neutron rocket, which is designed to compete with larger players like SpaceX for much bigger, more lucrative contracts. "Additionally, they're not just a launch company. Their Space Systems division - which builds satellite components and platforms - is their biggest revenue driver. They are strategically building an end-to-end space company, and their pending acquisition of the company Mynaric is another step in that direction." When it came to whether the 800 percent increase was sustainable, the level of share price was probably not, he said. "Unless the company's growth potential is even better than what people are currently thinking. However, the underlying business growth is there. There is a very real and rapidly growing company here. The ultimate test will be whether its fundamental performance can grow fast enough to justify the market's sky-high expectations. That said, if the balloon pops, it can go real fast, real quick."
RNZ News
7 hours ago
- RNZ News
What's really going on with Rocket Lab shares?
Photo: RNZ/ Nate McKinnon Rocket Lab may be recording multi-million-dollar losses, but its share price keeps on going up. Shares in the New Zealand-founded space company have risen more than 800 percent in the past year, to just under US$50 each. In August last year, they were changing hands for less than US$5. In its 2024 financial year, the company recorded a loss of US$33 million to US$35m, from record annual revenue of US$436.2m. Greg Smith, head of retail at Devon Funds, said investors were looking past the lack of profitability, and there was a lot of momentum priced in to its shares. "But the company has been delivering. It is gaining huge credibility through deals with national space agencies and spending here has been ramping up. There's been the recent partnership agreed with the European Space Agency to launch satellites for constellation navigation before December. "And there has been a string of successful launches. A rocket is being produced every 15 days, and [it has] successfully launched its 66th, 67th and 68th Electron rockets." He said the company's upcoming, bigger Neutron medium-lift rocket was another driver of growth. If it was successful, it could unlock US$5.6 billion in National Security Space Launch contracts. "The company isn't profitable yet, so we can't really look at earnings multiples. Even to sales it is looking high at up to 10 times, but if it keeps delivering we might yet see more momentum." Gretjan Verdickt, a lecturer of finance at the University of Auckland, said a significant portion of Rocket Lab's current valuation was based on the promise of a future that was "both exciting and challenging to value". "How much will the space economy truly be worth in 10 or 20 years? How many applications will it lead to? It's difficult for anyone to grapple with. Because of that uncertainty, optimistic investors are willing to pay a very high price today for the potential of a massive payoff down the road. They see a leader in a burgeoning industry and don't want to miss out. "This part of the valuation is precarious. A narrative of explosive growth and future dominance sustains it. If that optimism fades, even slightly, you could see a significant drop. That said, for anyone who got in early, a drop would still leave them with an amazing return." He said the "hype-driven" component of the share price made it fragile. "If you think about it from a behavioural finance point of view, there is a lot of 'fear of missing out' going on too. If you missed the boat at 100 percent, 200 percent... and you jump in late, the prices - because you are willing to buy - the stock price increases more. This leads to a momentum effect." He said the other aspect of the share price was the company's cash flow. "There is a real, tangible business generating real cash flows behind the stock price. "Rocket Lab has already realised tremendous growth. Their revenue has increased significantly over the past few years, and they have a backlog of over $1 billion in signed contracts, providing a clear line of sight into future earnings. "They have two core pillars of growth. First, their proven Electron rocket is a workhorse for the small satellite market. Second, and more importantly for the future, is their upcoming Neutron rocket, which is designed to compete with larger players like SpaceX for much bigger, more lucrative contracts. "Additionally, they're not just a launch company. Their Space Systems division - which builds satellite components and platforms - is their biggest revenue driver. They are strategically building an end-to-end space company, and their pending acquisition of the company Mynaric is another step in that direction." When it came to whether the 800 percent increase was sustainable, the level of share price was probably not, he said. "Unless the company's growth potential is even better than what people are currently thinking. However, the underlying business growth is there. There is a very real and rapidly growing company here. The ultimate test will be whether its fundamental performance can grow fast enough to justify the market's sky-high expectations. That said, if the balloon pops, it can go real fast, real quick."
